JNJ
Johnson & Johnson
Stock
$271.95+0.73 (+0.27%)Close Sep 28, 2026
Cash flow statement
| Line | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $27.6B | $24.5B | $24.3B | $22.8B | $21.2B | $23.4B | $23.5B | $23.4B | $22.2B | $21.1B | $18.8B | $19.6B | $18.7B | $17.4B | $15.4B | $14.3B | $16.4B | $16.6B | $15.0B | $15.0B |
| Capital expenditures | $5.4B | $4.8B | $4.4B | $4.5B | $4.0B | $3.7B | $3.3B | $3.5B | $3.7B | $3.3B | $3.2B | $3.5B | $3.7B | $3.6B | $2.9B | $2.9B | $2.4B | $2.4B | $3.1B | $2.9B |
| Free cash flow | $22.2B | $19.7B | $19.8B | $18.2B | $17.2B | $19.8B | $20.2B | $19.9B | $18.5B | $17.8B | $15.5B | $16.1B | $15.0B | $13.8B | $12.5B | $11.4B | $14.0B | $14.2B | $11.9B | $12.1B |
| Stock-based compensation | $1.4B | $1.4B | $1.2B | $1.2B | $1.1B | $1.1B | $1.0B | $977M | $978M | $962M | $878M | $874M | $792M | $728M | $662M | $621M | $614M | $628M | $627M | $698M |
| Buybacks | $8.1B | $6.0B | $2.4B | $5.1B | $6.0B | $3.5B | $3.2B | $6.7B | $5.9B | $6.4B | $9.0B | $5.3B | $7.1B | $3.5B | $12.9B | $2.5B | $2.8B | $2.1B | $6.7B | $5.6B |
| Dividends per share | $5.24 | $5.14 | $4.91 | $4.70 | $4.45 | $4.19 | $3.98 | $3.75 | $3.54 | $3.32 | $3.15 | $2.95 | $2.76 | $2.59 | $2.40 | $2.25 | $2.11 | $1.93 | $1.80 | $1.62 |
| Free cash flow margin | 22.7% | 20.9% | 22.3% | 21.4% | 21.5% | 25.1% | 24.4% | 24.3% | 22.7% | 23.3% | 21.6% | — | — | — | — | — | — | — | — | — |